Synthetic nucleotides are essential for molecular biology, and Qiagen has bought Operon (a company here in the US). With qiagen entering that field in Japan it means that they can use their knowledge and reputation to gain market share. Also, Qiagen also provides with kits to purify products of these nucleic acids, iow, they are covering their bases!I like qiagen, yet i am not holding it, should have gone in at 20, and probably will go back in once things correct a bit...amade
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Rat